Phreesia, Inc. Stock Prediction and Forecast [PHR]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 09 Dec 2025, 04:39 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for Phreesia, Inc. Stock Prediction and Forecast [PHR]](https://i.ytimg.com/vi/dxd5-NXmnZY/hqdefault.jpg)
AI-generated source summary
Phreesia (PHR) shows several negative signals and is in a wide and falling trend, indicating it will likely perform weakly in the short to medium term. The stock's current price is below key resistance levels ($20.62) and shows negative short-term and long-term moving average signals, suggesting a bearish outlook. Analysts have provided a mixed bag of ratings, with some indicating a 'Buy' or 'Outperform', while others suggest a 'Sell' or 'Strong Sell'. The price-to-earnings ratio is negative (-49.57), indicating losses. The stock has experienced significant daily volatility (4.22% weekly volatility) and has traded within a defined range over the last week. We are issuing a sell candidate evaluation for PHR. However, if the stock bounces off the support level at $20.05, it could present a short-term buying opportunity.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.